Gambro

In 2013, Baxter International acquired Gambro, making Gambro a wholly-owned subsidiary of Baxter. This acquisition bolstered Baxter's position in the renal therapy and associated services sector.

Gambro is a global medical technology company and a leader in developing, manufacturing and supplying products, therapies and services for In-center Care and Self Care Hemodialysis, Peritoneal Dialysis, Renal Intensive Care and Hepatic Care.

For decades, Gambro has led the market in renal care development and has been first to market with many groundbreaking innovations. Gambro is the only clinic-independent company and by designing and delivering complete solutions to dialysis clinics and intensive care units, Gambro offers not just improved treatment quality, but also improved efficiency.